ClinicalTrials.gg
Not yet recruitingNCT07150689Updated Sep 2, 2025

Outcome of Bronchoscopy in FB Aspiration

An interventional study of Rigid bronchoscopy and Flexible scope in Foreign Body Aspiration, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Day to 18 Years. Per ClinicalTrials.gov, last updated 2025-09-02.

Sponsored by Assiut University · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
1 Day to 18 Years
Sex
All
01

Study summary

Outcome of Bronchoscopy in Pediatric patient with foreign body aspiration

02

Conditions studied

  • Foreign Body Aspiration

Browse trials for

03

In context

Respiratory Aspiration

25 studies on the registry are indexed under Respiratory Aspiration; 6 are open to participants now.

This study's planned enrollment of 75 is above the median of 66 across 18 interventional studies indexed under Respiratory Aspiration.

Browse Respiratory Aspiration studies →

Lead sponsor

Assiut University is the lead sponsor of 5,094 studies on the registry; 2,187 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children less than 18 years with suspected foreign body aspiration

Exclusion criteria

Exclusion Criteria:

  • children with congenital airway anomalies other than foreign body aspiration
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
75 participants (estimated)

Study arms

  • Active comparator
    Rigid Bronchoscopy

    Standard of care in most pediatric centers; performed under general anesthesia to visualize and remove FB. Gold standard for both diagnosis and treatment

    Procedure: Rigid bronchoscopy

  • Experimental
    Flexible Bronchoscop

    Flexible scope used for diagnosis and sometimes removal (especially in distal airways or when FB is small). Evaluate if less invasive flexible bronchoscopy can be effective.

    Procedure: Flexible scope

  • Experimental
    Combined Approach

    Initial flexible bronchoscopy for diagnosis and airway inspection, followed by rigid bronchoscopy for removal if needed. Compare efficiency and safety of combined method.

    Procedure: Combined Flexible-Rigid Bronchoscopy

  • Experimental
    Imaging-Guided Approach

    High-resolution CT or virtual bronchoscopy first; bronchoscopy only if imaging suggests FB. Assess if imaging can reduce unnecessary bronchoscopies.

    Procedure: Imaging-Guided Bronchoscopy

Interventions

  • ProcedureRigid bronchoscopy

    Participants will undergo rigid bronchoscopy under general anesthesia using an age-appropriate rigid bronchoscope. The airway will be systematically inspected. Any identified foreign body will be removed using appropriate retrieval devices (optical forceps, retrieval basket, suction). Post-removal, the airway will be re-examined to confirm clearance and detect trauma.

  • ProcedureFlexible scope

    Participants will undergo flexible fiberoptic bronchoscopy under sedation or general anesthesia. The bronchoscope will be inserted transorally or transnasally. The airway will be inspected, and foreign body retrieval attempted using retrieval baskets, forceps, or cryoprobe

  • ProcedureCombined Flexible-Rigid Bronchoscopy

    Initial flexible bronchoscopy will be performed to locate the foreign body and inspect distal airways, followed by rigid bronchoscopy for definitive removal.

  • ProcedureImaging-Guided Bronchoscopy

    Participants will undergo pre-procedure high-resolution CT or virtual bronchoscopy. Based on imaging, either rigid or flexible bronchoscopy will be performed, targeting the suspected location to reduce procedure time.

06

What researchers measure

Primary outcomes

  1. Rate of Successful Foreign Body Removal

    The proportion of patients in whom the foreign body is completely removed during the initial bronchoscopy procedure, as confirmed by direct visualization and/or post-procedure imaging.

    Time frame: During bronchoscopy procedure (intra-operative, within 24 hours of intervention).

Secondary outcomes

  1. Incidence of procedure-related complications (within 24 hours).

    Number of patients who experience complications such as hypoxia (SpO₂ \< 90%), bleeding, airway trauma, pneumothorax, or cardiac arrhythmia.

    Time frame: Intra-procedure and up to 24 hours post-procedure.

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2025; primary completion for Oct 2026, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 8, 2025
First posted
Sep 2, 2025
StartEst.
Oct 2025
Primary completionEst.
Oct 2026
CompletionEst.
Oct 2026
Last update
Sep 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07150689
Lead sponsor
Assiut University
Responsible party
Marsail Refat Kadry (Resident, Assiut University) — Principal investigator
First posted
Sep 2, 2025
Start date
Oct 2025 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Sep 2, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion